GlassScriptPhysician profile
Agnes Aondo
NPI 1265982698
$819.82
in general payments reported to CMS, 2019-2025
20 companies · $223 in 2025
The $223 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $446 · 2022: $18.93 · 2023: $97.63 · 2024: $33.97 · 2025: $223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $354.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $149.38 | 2021-2024 | |
| Lilly USA, LLC | $113.08 | 2021-2025 | Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $112.26 | 2025 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $85.53 | 2021 | |
| Novo Nordisk INC | $62.62 | 2021-2024 | Wegovy |
| Exact Sciences Corporation | $35.59 | 2025 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.37 | 2021 | |
| Merck Sharp & Dohme LLC | $27.59 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $26.79 | 2021-2025 | Zoryve |
| Currax Pharmaceuticals LLC | $24.55 | 2021 | |
| Lundbeck LLC | $20.97 | 2023 | Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $18.95 | 2021 | |
| Glaxosmithkline, LLC. | $18.44 | 2023 | Pediarix, Bexsero |
| Cipher Pharmaceuticals US LLC | $16.12 | 2025 | Natroba, Spinosad |
| Biogen, INC. | $15.16 | 2025 | Zurzuvae |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $13.65 | 2021 | |
| Arbor Pharmaceuticals, INC. | $13.59 | 2021 | |
| Dexcom, INC. | $12.42 | 2021 | |
| Amgen INC. | $12.20 | 2021 | |
| Ironwood Pharmaceuticals, INC | $11.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Agnes Aondo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.